Research
Energy balance
Current evidence on the cardiovascular safety of tirzepatide is limited but suggestive.
Caution is advised when considering tirzepatide for patients with cardiovascular issues due to limited evidence.
GoodQualifiesmedium confidence
Current evidence is limited, although suggestive of the cardiovascular safety of tirzepatide.
Why this rating
The claim is based on a review of existing evidence, which is less robust than a primary study.
Source
Tirzepatide for the Treatment of Heart Failure in Type 2 Diabetes Mellitus: (SUR)PASS, or Not?
Dimitrios Patoulias et al. · Future Cardiology · 2023
DOI 10.2217/fca-2022-0112
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →